Order Article Reprints

Bornstein-Quevedo L, de Anda-González J, Lara-Torres CO, Flores-Gutiérrez JP, Dorantes-Heredia R, Bautista-Piña V, Zaragoza-Vargas P, Alcaraz-Wong A, Soto-Sañudo AK, Mendoza-Ramírez S, et al. Navigating HER2-Low Testing in Invasive Breast Cancer: Update Recommendations for Pathologists. Journal of Personalized Medicine. 2024; 14(5):467. https://doi.org/10.3390/jpm14050467

Bornstein-Quevedo, Leticia, Jazmín de Anda-González, Cesar Octavio Lara-Torres, Juan Pablo Flores-Gutiérrez, Rita Dorantes-Heredia, Verónica Bautista-Piña, Perla Zaragoza-Vargas, Aldo Alcaraz-Wong, Ana Karen Soto-Sañudo, Saulo Mendoza-Ramírez, and et al. 2024. "Navigating HER2-Low Testing in Invasive Breast Cancer: Update Recommendations for Pathologists" Journal of Personalized Medicine 14, no. 5: 467. https://doi.org/10.3390/jpm14050467

Bornstein-Quevedo, L., de Anda-González, J., Lara-Torres, C. O., Flores-Gutiérrez, J. P., Dorantes-Heredia, R., Bautista-Piña, V., Zaragoza-Vargas, P., Alcaraz-Wong, A., Soto-Sañudo, A. K., Mendoza-Ramírez, S., Salamanca-García, M., Loyola-Rodríguez, G., Gómez-Macías, G. S., Murguia-Perez, M., De Luna-Sánchez, M., Villalobos-Valencia, R., Talamantes, E., & Arce-Salinas, C. (2024). Navigating HER2-Low Testing in Invasive Breast Cancer: Update Recommendations for Pathologists. Journal of Personalized Medicine, 14(5), 467. https://doi.org/10.3390/jpm14050467